Gaois

This is a static copy of data that is exported from IATE on an occasional basis. It should not be assumed that information provided about an entry here will always correspond to the current version of the entry in IATE. That current version can be checked by clicking on the link on the upper right hand side of each entry. More information »

1 result

  1. SOCIAL QUESTIONS|health|pharmaceutical industry
    scor de dhúshlán Reference Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Auslassversuch
    de
    Definition Absetzen eines verdächtigen Arzneimittels Reference Elena Keller: "Unerwünschte Arzneimittelwirkungen: Ansätze zur Inzidenzschätzung und Signalgenerierung mit fallbasierten Pharmakovigilanzdaten", Institut für Medizinische Informationsverarbeitung, Biometrie und Epidemiologie der Universität München, Dissertation, 2006 http://edoc.ub.uni-muenchen.de/5207/1/Keller_Elena.pdf (16.4.2012)
    Comment man unterscheidet negative und positive Auslassversuche
    dechallenge
    en
    Definition clinical decision to withdraw/discontinue a drug treatment after a possible adverse drug reaction has occurred Reference 'Dictionary of Pharmacovigilance', Amer Alghabban, Pharmaceutical Press; 2004, p. 136, http://books.google.be/books?id=t9PfXItFKHIC&pg=PA408&lpg=PA408&dq=negative+rechallenge&source=bl&ots=Yv08Oh8z83&sig=HrmrrxSd5hh2MbspAwS5CzYayZA&hl=en&redir_esc=y#v=onepage&q=dechallenge&f=false
    Comment If the suspected adverse drug reaction persists (without corrective treatment), then there is negative dechallenge, whereas if it disappears (without corrective treatment), there is positive dechallenge). Reference: European Medicines Agency. Evaluation, validation, prioritisation and reporting signals from the review of CIOMS forms and line listings http://www.ema.europa.eu/docs/en_GB/document_library/Work_Instruction_-_WIN/2009/09/WC500002898.pdf [20.4.2012]
    déchallenge | arrêt du traitement | interruption du traitement
    fr
    Definition arrêt/interruption de l'administration d'un produit à la suite de l'apparition d'un effet indésirable Reference COM-FR, d'après:Swissmedic, Procédure standard, Assurance qualité des annonces d'EI, Accord conclu entre les centres régionaux de pharmacovigilance et Swissmedic, version 2